Back to News
Feb 12, 2026 8:20 AM

Alnylam Pharmaceuticals Q4 Earnings Assessment

Alnylam Pharmaceuticals (NASDAQ:ALNY) released its Q4 earnings on Thursday, February 12, 2026 at 08:00 AM.

Here's what's important from the earnings announcement.

Earnings

Alnylam Pharmaceuticals beat estimated earnings by 4.17%, reporting an EPS of $1.25 versus an estimate of $1.2.

Revenue was up $503.87 million from the same period last year.

Earnings History Overview

During the previous quarter, the company beat ...